Deutsche Bank announced on Friday that it had raised its target price for Clariant from 13.5 to 15 Swiss francs, ahead of the publication of the Swiss specialty chemicals group's second-quarter results on July 30.

The analyst expects adjusted operating profit (Ebitda) to rise by 31.5% year-on-year, to 184 million francs, against a consensus of 167 million.

The intermediary explains that he expects improved performance in skin care products, absorbers and additives, which he believes should more than offset weakness in catalysts.

DB also believes that it is not impossible for the Swiss chemical company to raise its annual targets, pointing out that it is currently targeting a 1% to 3% increase in sales in local currencies this year, with an operating margin (Ebitda) of 15%.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.